Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

NCT00711958 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: HX575, solution for injection (s.c.)
DRUG: ERYPO®, Janssen-Cilag, solution for injection (s.c.)

Sponsor

Sandoz

Collaborators

[object Object]